PYROMELLITIC DIANHYDRIDE | ICSC: 1375 (March 2001) |
1,2,4,5-Benzenetetracarboxylic 1,2:4,5-dianhydride 1,2,4,5-Benzenetetracarboxylic anhydride 1H,3H-Benzo(1,2-c;4,5-c')difuran-1,3,5,7-tetrone PMDA |
CAS #: 89-32-7 |
EC Number: 201-898-9 |
ACUTE HAZARDS | PREVENTION | FIRE FIGHTING | |
---|---|---|---|
FIRE & EXPLOSION | Combustible. | NO open flames. | Use water spray, powder, foam, carbon dioxide. |
PREVENT DISPERSION OF DUST! | |||
---|---|---|---|
SYMPTOMS | PREVENTION | FIRST AID | |
Inhalation | Cough. Sore throat. Wheezing. Shortness of breath. | Use local exhaust or breathing protection. | Fresh air, rest. Half-upright position. Refer for medical attention. |
Skin | Redness. Burning sensation. | Protective gloves. Protective clothing. | Remove contaminated clothes. Rinse skin with plenty of water or shower. |
Eyes | Redness. Pain. Blurred vision. | Wear safety goggles or eye protection in combination with breathing protection. | First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention. |
Ingestion | Burning sensation. | Do not eat, drink, or smoke during work. Wash hands before eating. | Rinse mouth. Do NOT induce vomiting. |
SPILLAGE DISPOSAL | CLASSIFICATION & LABELLING |
---|---|
Personal protection: particulate filter respirator adapted to the airborne concentration of the substance. Sweep spilled substance into covered containers. If appropriate, moisten first to prevent dusting. Wash away remainder with plenty of water. |
According to UN GHS Criteria Transportation |
STORAGE | |
Dry. Well closed. | |
PACKAGING | |
PYROMELLITIC DIANHYDRIDE | ICSC: 1375 |
PHYSICAL & CHEMICAL INFORMATION | |
---|---|
Physical State; Appearance
Physical dangers
Chemical dangers
|
Formula: C10H2O6 / C6H2(C2O3)2 |
EXPOSURE & HEALTH EFFECTS | |
---|---|
Routes of exposure
Effects of short-term exposure
|
Inhalation risk
Effects of long-term or repeated exposure
|
OCCUPATIONAL EXPOSURE LIMITS |
---|
ENVIRONMENT |
---|
NOTES |
---|
The symptoms of asthma often do not become manifest until a few hours have passed and they are aggravated by physical effort. Rest and medical observation are therefore essential. Anyone who has shown symptoms of asthma due to this substance should avoid all further contact. |
ADDITIONAL INFORMATION | ||
---|---|---|
EC Classification Symbol: Xn; R: 41-42/43; S: (2)-22-24-26-37/39 |
All rights reserved. The published material is being distributed without warranty of any kind, either expressed or implied. Neither ILO nor WHO nor the European Commission shall be responsible for the interpretation and use of the information contained in this material. | |